SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001161697-11-000168
Filing Date
2011-02-23
Accepted
2011-02-23 15:28:34
Documents
2
Period of Report
2011-02-18
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K FOR 02-18-2011 form_8-k.htm 8-K 15646
2 AMENDMENT TO BYLAWS ex_3-1.htm EX-3 3961
  Complete submission text file 0001161697-11-000168.txt   21313
Mailing Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071
Business Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071 86-10-63899868
Lotus Pharmaceuticals, Inc. (Filer) CIK: 0001292087 (see all company filings)

IRS No.: 200507918 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32581 | Film No.: 11632061
SIC: 2834 Pharmaceutical Preparations